Drug Type Biosimilar, Monoclonal antibody |
Synonyms Golimumab Biosimilar (Bionovis SA) |
Target |
Action inhibitors |
Mechanism TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseUnknown |
First Approval Date- |
Regulation- |














